Анализ акций 524632.BO
52
Нет оценки
Количественный анализ Eyestock не покрывает акции Shukra Pharmaceuticals Ltd.
Капитализация млрд. $
0.001
Дивидендная доходность
0.56 %
Оборот
43.79 млрд
Сайт компании
http://www.shukrapharmaceuticals.com/Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. The company is headquartered in Ahmedabad, Gujarat. The firm operates in two sectors: pharmaceutical and laboratory. The firm's manufacturing plant is situated in Rakanpur, Gandhinagar. The firm's product portfolio includes antibiotics (penicillin), anti-biotics (cephalosporin), anti-biotics, macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, analgesic (NASID), muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic. The firm is engaged in manufacturing general formulations, such as tablets, capsules and small volume parenteral.